1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/13/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 258.71% | HC Wainwright & Co. | Andrew Fein | $90 → $90 | Maintains | Buy | Get Alert |
02/20/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 218.85% | Oppenheimer | Jay Olson | $98 → $80 | Maintains | Outperform | Get Alert |
02/16/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 238.78% | JMP Securities | Jason Butler | $81 → $85 | Maintains | Market Outperform | Get Alert |
02/16/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 39.5% | RBC Capital | Brian Abrahams | $36 → $35 | Maintains | Sector Perform | Get Alert |
01/30/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 51.45% | B of A Securities | Tazeen Ahmad | $68 → $38 | Downgrade | Buy → Neutral | Get Alert |
01/25/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 43.48% | RBC Capital | Brian Abrahams | $43 → $36 | Maintains | Sector Perform | Get Alert |
01/09/2024 | PRTA | Buy Now | Prothena Corp | $25.09 | 246.75% | Cantor Fitzgerald | Charles Duncan | $129 → $87 | Maintains | Overweight | Get Alert |
12/18/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 414.15% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
12/12/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 147.11% | Deutsche Bank | Neena Bitritto-Garg | → $62 | Initiates | → Buy | Get Alert |
11/03/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 222.84% | JMP Securities | Jason Butler | $83 → $81 | Maintains | Market Outperform | Get Alert |
10/23/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 414.15% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 414.15% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
08/04/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 258.71% | HC Wainwright & Co. | Andrew Fein | → $90 | Reiterates | Buy → Buy | Get Alert |
08/04/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 230.81% | JMP Securities | Jason Butler | $82 → $83 | Maintains | Outperform | Get Alert |
07/18/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 414.15% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
07/18/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 258.71% | HC Wainwright & Co. | Andrew Fein | → $90 | Reiterates | Buy → Buy | Get Alert |
07/11/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 414.15% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
07/11/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 226.82% | JMP Securities | Jason Butler | → $82 | Reiterates | Market Outperform → Market Outperform | Get Alert |
06/28/2023 | PRTA | Buy Now | Prothena Corp | $25.09 | 414.15% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by HC Wainwright & Co. on March 13, 2024. The analyst firm set a price target for $90.00 expecting PRTA to rise to within 12 months (a possible 258.71% upside). 27 analyst firms have reported ratings in the last year.
The latest analyst rating for Prothena Corp (NASDAQ: PRTA) was provided by HC Wainwright & Co., and Prothena Corp maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Prothena Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Prothena Corp was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.
While ratings are subjective and will change, the latest Prothena Corp (PRTA) rating was a maintained with a price target of $90.00 to $90.00. The current price Prothena Corp (PRTA) is trading at is $25.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.